Psychobiotics Market to Grow with an Impressive CAGR During the Forecast Period
Advancing healthcare industry is driving the growth in
Global Psychobiotics Market in the forecast period, 2022-2026.
According to TechSci Research report, “Global Psychobiotics
Market
By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant
Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus,
Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By Distribution
Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online) By
Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism
Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia,
Others) By Region, Competition Forecast & Opportunities, 2026”, the global psychobiotics market may potentially project an impressive
growth in the forecast period, 2022-2026, with an impressive CAGR on the
account of rising number of depression and anxiety cases among the population.
The young population is more inclined toward self-diagnosing and
self-medication, and along with the health concerns among the population, the
market is anticipated to show robust growth in the future five years. Moreover,
easier availability of the psychobiotics in the form of food supplements,
nutritional supplements, and special nutrients; the market is bound to
experience the anticipated growth in the CAGR in upcoming five years.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Psychobiotics Market"
https://www.techsciresearch.com/report/psychobiotics-market/7678.html
The global psychobiotics market is segmented by
type, psychotropic agent, form, distribution channel, application,
competitional landscape, and regional distribution. Based on psychotropic
agent, the market is further bifurcated into Streptococcus, Lactobacillus,
Clostridium, and others. Streptococcus is a genus of bacteria that is
gram-positive and belongs to the family of Straptococcaceae. The bacteria are
taken in its inactive form and through biotechnological procedures is abetted
for the procedure of manufacturing psychobiotics. Bifidobacterium is also a
gram-positive anaerobic bacterium that is inhabitant to human gastrointestinal
tract. The bacteria are affective in psychological anxiety and stress ailments
along with its widely pronounced functions in digestion.
Based on type, the market is further segmented into
food supplements, nutritional supplements, specialty nutrients, and infant
formula. Nutritional supplements are anticipated to hold the largest revenue
shares of the market and assert its dominance over the market on the account of
rapidly growing number of consumers inclined toward self-medication. The
consumers are eagerly adapting the psychobiotics as a nutritional supplement
for healthy brain. Large population is suffering from depression, stress and
anxiety. The tendency of self-diagnosing and self-medication is very active
among the young population and thus they are aiding to the growth of the global
psychobiotics market in the upcoming five years forecast, until 2026.
Holding the major shares of the global
psychobiotics market are Innovix Labs, Bened Biomedical Co., Ltd, Nutrimmun
GmbH, Kerry Group Plc., Sabinsa Corporation, Lallemand Health Solutions Inc.,
DuPont de Nemours, Inc., Uplift Food Pty Ltd., Nature's Bounty Co. Ltd.,
BioGaia Group, The Life Extension Foundation, Lifted Naturals, among others.
Market players are actively involved in the research and technological
development in the medical device and testing kit developments. The advanced
technology has made it possible for the healthcare industry to provide
excellent healthcare services through psychobiotics. Further advancement would
aid the market value and brand establishment in the future five years. New
market players may focus on the research and development to provide options
that satisfies the consumer demand as well as benefits the market players in
building their brand value. Other competitive strategies include mergers &
acquisitions and new product developments.
Download Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=7678
Customers can also request for
10% free customization on this report.
“North America is
anticipated to be the most volatile and most promising market in the future
five years. The region consists of the United States and Canada likewise major
economies that support excellent healthcare within the country and the presence
of multiple market players that hold major shares of the market are other major
factors that is expected to support the growth of the market too. Moreover, the
consumers of the United States are accounting to maximum number of consumers
along with the rapidly growing health-conscious consumers. Asia Pacific may
also register itself as a self-reliant market in the next five years on the
account of rapidly evolving healthcare industry in the region as well as
rapidly increasing cases of depression and anxiety,” said Mr. Karan Chechi,
Research Director with TechSci Research, a research based Global management
consulting firm.
“Global Psychobiotics
Market By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients,
Infant Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium,
Lactobacillus, Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By
Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug
Store/Pharmacy, Online) By Application (Gastrointestinal Function,
Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit
Hyperactivity Disorder, Schizophrenia, Others) By Region, Competition Forecast
& Opportunities, 2026”,
has evaluated the future growth potential of global psychobiotics and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global psychobiotics market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/